|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-10-26
|
|
pubmed:abstractText |
Evidence is accumulating that statins can reduce proteinuria and disease progression in chronic kidney disease. However, some safety concerns have been recently raised on the use of these agents, mainly due to transient episodes of proteinuria observed in patients receiving high doses of rosuvastatin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9670
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2007 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
630-8
|
|
pubmed:meshHeading |
pubmed-meshheading:17851231-Animals,
pubmed-meshheading:17851231-Capillaries,
pubmed-meshheading:17851231-Capillary Permeability,
pubmed-meshheading:17851231-Disease Models, Animal,
pubmed-meshheading:17851231-Fluorobenzenes,
pubmed-meshheading:17851231-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:17851231-Kidney Glomerulus,
pubmed-meshheading:17851231-Proteinuria,
pubmed-meshheading:17851231-Pyrimidines,
pubmed-meshheading:17851231-Rats,
pubmed-meshheading:17851231-Rats, Sprague-Dawley,
pubmed-meshheading:17851231-Sulfonamides
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation.
|
|
pubmed:affiliation |
Mario Negri Institute for Pharmacological Research, Ospedali Riuniti di Bergamo, Bergamo, Italy.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
